Gottlieb Stresses Importance of Patient Voice in Benefit-Risk Assessments

FDA Commissioner Scott Gottlieb announced an update of the agency’s framework for using benefit-risk assessments in drug reviews and said he wants to improve the assessments by making increased use of patient perspectives.
Source: Drug Industry Daily